Davidson
NE
Select, Recent Publications
Primary
systemic therapy in operable breast cancer. [Review].
Wolff
AC, Davidson NE. Journal of Clinical Oncology. 2000;18:1558-69.
Combined
endocrine therapy for breast cancer--new life for an old idea?
[editorial; comment].
Davidson
NE. Journal of the National Cancer Institute. 2000;92:859-60.
American
Society of Clinical Oncology 1998 update of recommended breast
cancer surveillance guidelines.
Smith
TJ, Davidson NE, Schapira DV, et al. Journal of Clinical Oncology.
1999;17:1080-2.
Locoregional
failure 10 years after mastectomy and adjuvant chemotherapy
with or without tamoxifen without irradiation: experience
of the Eastern Cooperative Oncology Group.
Recht
A, Gray R, Davidson NE, et al. Journal of Clinical Oncology.
1999;17:1689-700.
The
biology of breast cancer. [Review].
Nass
SJ, Davidson NE. Hematology - Oncology Clinics of North America.
1999;13:311-32.
Long
term follow-up of women treated with 16-week, dose-intensive
adjuvant chemotherapy for high risk breast carcinoma.
Mikhak
B, Zahurak M, Abeloff MD, et al. Cancer. 1999;85:899-904.
Clinical
aspects of cell death in breast cancer: the polyamine pathway
as a new target for treatment. [Review].
Davidson
NE, Hahm HA, McCloskey DE, Woster PM, Casero RA Jr. Endocrine-Related
Cancer. 1999;6:69-73.
The
loss of estrogen and progesterone receptor gene expression
in human breast cancer. [Review].
Lapidus RG, Nass SJ, Davidson NE. Journal of Mammary Gland
Biology & Neoplasia. 1998;3:85-94.
Environmental
estrogens and breast cancer risk. [Review].
Davidson
NE. Current Opinion in Oncology. 1998;10:475-8.
Dose-dense
sequential chemotherapy followed by high-dose consolidation
(hdc): a phase i study in women with high-risk node-positive
breast cancer (BC) (Meeting abstract).
Kennedy
MJ, Bond S, Davidson NE, et al. Proc Annu Meet Am Soc Clin
Oncol. 17:A355, 1998.
Minimal
acute toxicity associated with locoregional radiation therapy
following 2 high-dose chemotherapy regimens (hdc) supported
with autologous marrow/stem-cell transplantation in high risk
breast cancer patients (Meeting abstract).
Gage
I, Bond S, Davidson NE, et al. Proc Annu Meet Am Soc Clin
Oncol. 17:A463, 1998.
|